While response rates are low for CTLA4 and PD-L1 immune checkpoint inhibition in metastatic uveal melanoma, other immune checkpoints are at play and increasing the T- and NK- cell response in the metastatic niche may inhibit both survival and growth of uveal melanoma micrometastases [103]. This evidence concerns the gene CTLA4 and uveal melanoma.